Edit

Evolva

http://www.evolva.com/

Last activity: 08.01.2024

Categories: BioTechHealthTechProductResearchScienceServiceTechnologyWellness

Evolva is a biotech researching, developing and commercializing nature-based ingredients for flavors and fragrances, health ingredients and health protection.

Mentions

Twitter

Investors 2

Date	Name	Website
-	Auriga Par...	auriga.vc
-	Wellington...	wellington...

Mentions in press and media 24

Date	Title	Description	Source
08.01.2024	Canadian Yeast Specialist Lallemand Acquires Swiss Biotech C...	Lallemand Inc., a Canadian company specializing in yeast-based ingredients, has confirmed that its s...	vegconomis...
23.11.2023	Evolva: a CHF 20 million exit deal prevents company closure	On 14 June 2023, the Board of Directors (BOD) of Evolva initiated a comprehensive review of strate...	startuptic...
24.08.2022	Swiss biotechs in dispute with regulators	Pharvaris develops drug candidates for a rare and potentially life-threatening genetic condition c...	startuptic...
08.02.2022	Evolva appoints Christian Wichert as new CEO to boost growth...	Evolva Holding SA / Key word(s): Personnel Evolva appoints Christian Wichert as new CEO to boost gr...	marketscre...
27.12.2021	Evolva secures additional financing lines to accelerate its ...	EQS-Ad-hoc: Evolva Holding SA / Key word(s): Financing Evolva secures additional financing lines to...	marketscre...
30.11.2021	Evolva announces private placement of 63.8m shares to VERAIS...	EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous Evolva announces private placement...	marketscre...
10.09.2021	Evolva : HY 2021 Results Presentation (EN)	HY 2021 Results presentation August 26, 2021 Agenda Highlights 4 Strategic priorities 7 Busi...	marketscre...
26.08.2021	Evolva : Half Year Results presentation 2021 (EN)	HY 2021 Results presentation August 26, 2021 Agenda Highlights 4 Strategic priorities 7 Busi...	marketscre...
17.05.2021	EVOLVA HOLDING SA Evolva : secures additional funding for f...	EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous Evolva secures additional funding ...	marketscre...
03.12.2020	The People’s Vaccine—Moderna’s Coronavirus Vaccine Was Large...	Coronavirus Covid-19 Protection and Vaccine. getty Moderna just announced exciting new results for ...	forbes.com...
24.09.2020	Aquatic biopesticide startup Sundew closes $1.7m seed round	As with terrestrial livestock, pests and diseases can wreak havoc on fish farms. But some of today’s...	agfunderne...
20.10.2017	SPECIAL REPORT: Navigating the vanilla flavors market	Vanilla bean prices surged in the early 2000s before crashing and then stabilizing for some years, E...	foodnaviga...
10.08.2016	Evolva collaborates with US Navy	Evolva’s collaboration with US Navy to focus on resveratrol-based composites	wellington...
27.07.2016	ETH spin-off develops solution for Zika Virus	Evolva was founded as a spin-off of ETH Zurich and is listed on SIX Swiss Exchange. Evolva has dev...	startuptic...
05.07.2016	A Closer Look at Cellular Agriculture and the Processes Defi...	Editor’s Note: Cellular agriculture is a method of agricultural production enabling the growth of me...	agfunderne...
28.09.2015	Synthetic Biology Is Not Just Good, It’s Good For You	Emily Leproust Contributor Emily Leproust is CEO of Twist Bioscience. More posts by this contribut...	techcrunch...
26.08.2015	Lux Research: Cost, speed & sustainability benefits of s...	While definitions of synthetic biology vary – and some firms feel the ‘synbio’ moniker is unhelpful ...	foodnaviga...
21.08.2015	5 Questions with Tate & Lyle Ventures as Firm Launches S...	Focusing on investments in high-growth companies innovating in the field of food sciences and techno...	agfunderne...
21.11.2014	Nützliche Phantasie und konkrete Politik	Der Tag in Basel startete gleich mit einem Highlight: dem Referat von Bundesrat Johann Schneider-A...	startuptic...
24.09.2014	Synthetic biology is cheaper, faster, and more sustainable, ...	And if what emerges from the fermentation process is chemically indistinguishable from what is extra...	foodnaviga...
28.08.2014	So Häagen-Dazs ‘says no to synbio’?	Now asking a company a question, getting the answer and using this as the hook for a press release t...	foodnaviga...
06.03.2013	Evolva to raise up to CHF 31.3 million	Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) today announces the start of its capital inc...	startuptic...
14.07.2010	Cleveland Clinic-led cardiovascular technology incubator aim...	“The thing that attracted us most to the Clinic and the GCIC was its blending of science and technol...	medcitynew...
-	Cleveland Clinic-led cardiovascular technology incubator aim...	The Global Cardiovascular Innovation Center incubator building is beginning to fill up. The $19-mil...	medcitynew...

Evolva

Investors 2

Mentions in press and media 24

Reviews 0